Efficacy and safety of long-acting risperidone in schizophrenic stable subjects durring 6 months period

被引：0
|
作者：
Gugleta, D. G. [1 ]
Slaykovic, Vs. [1 ]
Golubovic, S. T. G. Tosic [1 ]
Sibinovic, V. S. [1 ]
Stankovic, S. D. [1 ]
机构：
[1] Psychiat Clin, Nish, Serbia
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2010年 / 20卷
关键词：
D O I：
10.1016/S0924-977X(10)70736-7
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S496 / S496
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of long-acting risperidone in stable patients with schizoaffective disorder
    Lasser, R
    Bossie, CA
    Gharabawi, G
    Eerdekens, M
    Nasrallah, HA
    JOURNAL OF AFFECTIVE DISORDERS, 2004, 83 (2-3) : 263 - 275
  • [2] Long-acting injectable risperidone: Efficacy and safety
    Kane, JM
    Eerdekens, M
    Keith, SJ
    Lesem, M
    Karcher, K
    Lindenmayer, JP
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S325 - S325
  • [3] Long-acting risperidone, efficacy and safety of a new risperidone formulation
    Chinchilla, A
    Vega, M
    Quintero, J
    Yañez, R
    Correas, J
    Crespo, D
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S238 - S238
  • [4] Risperidone long-acting injectable improves efficacy and safety in schizophrenic patients after changing from oral risperidone
    Kusters, J
    Glue, P
    Katsafouros, K
    Boon, H
    Medori, R
    Parellada, E
    EUROPEAN PSYCHIATRY, 2005, 20 : S79 - S79
  • [5] Efficacy and safety of a novel long-acting risperidone formulation
    Kane, J
    Eerdekens, M
    Keith, S
    Lesem, M
    Karcher, K
    Lindenmayer, JP
    EUROPEAN PSYCHIATRY, 2002, 17 : 193S - 193S
  • [6] Comparative efficacy and safety of long-acting risperidone and risperidone oral tablets
    Chue, P
    Eerdekens, M
    Augustyns, I
    Lachaux, B
    Molcan, P
    Eriksson, L
    Pretorius, H
    David, AS
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 (01) : 111 - 117
  • [7] Efficacy and safety of long-acting risperidone microspheres and risperidone oral tables
    Chue, P
    Eerdekens, M
    Augustyns, I
    Lachaux, B
    Molcan, P
    Eriksson, L
    Pretorius, H
    David, A
    SCHIZOPHRENIA RESEARCH, 2002, 53 (03) : 174 - 175
  • [8] Long-acting injectable risperidone: Efficacy and safety of the first long-acting atypical antipsychotic
    Kane, JM
    Eerdekens, M
    Lindenmayer, JP
    Keith, SJ
    Lesem, M
    Karcher, K
    AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (06) : 1125 - 1132
  • [9] Efficacy and safety of risperidone long-acting injectable in stable psychotic patients previously treated with oral risperidone
    Schmauss, Max
    Sacchetti, Emilio
    Kahn, Jean-Pierre
    Medori, Rossella
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2007, 22 (02) : 85 - 92
  • [10] Efficacy and safety of a novel long-acting risperidone microspheres formulation
    Kane, J
    Eerdekens, M
    Keith, S
    Lesem, M
    Karcher, K
    Lindenmayer, JP
    BIOLOGICAL PSYCHIATRY, 2002, 51 (08) : 167S - 167S
12345